

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | central nervous system myelination (GO:0022010) | 6.11739102 |
| 2 | axon ensheathment in central nervous system (GO:0032291) | 6.11739102 |
| 3 | neuron cell-cell adhesion (GO:0007158) | 5.99436072 |
| 4 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 5.42589667 |
| 5 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 5.29735757 |
| 6 | dopamine biosynthetic process (GO:0042416) | 5.21564085 |
| 7 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 5.03799100 |
| 8 | ATP synthesis coupled proton transport (GO:0015986) | 5.03799100 |
| 9 | establishment of protein localization to Golgi (GO:0072600) | 4.75826729 |
| 10 | presynaptic membrane assembly (GO:0097105) | 4.64151206 |
| 11 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 4.48925296 |
| 12 | long-chain fatty acid biosynthetic process (GO:0042759) | 4.48346367 |
| 13 | presynaptic membrane organization (GO:0097090) | 4.45183330 |
| 14 | fatty acid elongation (GO:0030497) | 4.37526691 |
| 15 | negative regulation of neurotransmitter transport (GO:0051589) | 4.35247540 |
| 16 | respiratory electron transport chain (GO:0022904) | 4.33908247 |
| 17 | dopamine transport (GO:0015872) | 4.29504474 |
| 18 | electron transport chain (GO:0022900) | 4.23966117 |
| 19 | protein targeting to Golgi (GO:0000042) | 4.22837893 |
| 20 | neurotransmitter catabolic process (GO:0042135) | 4.01840045 |
| 21 | neural tube formation (GO:0001841) | 3.98054743 |
| 22 | neuron remodeling (GO:0016322) | 3.97002802 |
| 23 | neuron recognition (GO:0008038) | 3.95304717 |
| 24 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 3.95220525 |
| 25 | positive regulation of synapse assembly (GO:0051965) | 3.86701918 |
| 26 | regulation of catecholamine metabolic process (GO:0042069) | 3.85722940 |
| 27 | regulation of dopamine metabolic process (GO:0042053) | 3.85722940 |
| 28 | transmission of nerve impulse (GO:0019226) | 3.79383030 |
| 29 | protein K11-linked deubiquitination (GO:0035871) | 3.76352641 |
| 30 | myelination (GO:0042552) | 3.69490626 |
| 31 | protein neddylation (GO:0045116) | 3.66449100 |
| 32 | ensheathment of neurons (GO:0007272) | 3.62044065 |
| 33 | axon ensheathment (GO:0008366) | 3.62044065 |
| 34 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 3.61838363 |
| 35 | mating behavior (GO:0007617) | 3.59423532 |
| 36 | monoubiquitinated protein deubiquitination (GO:0035520) | 3.54639148 |
| 37 | substantia nigra development (GO:0021762) | 3.54212418 |
| 38 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 3.52049814 |
| 39 | prenylation (GO:0097354) | 3.46995899 |
| 40 | protein prenylation (GO:0018342) | 3.46995899 |
| 41 | glycerophospholipid catabolic process (GO:0046475) | 3.43408186 |
| 42 | synaptic transmission, dopaminergic (GO:0001963) | 3.42455093 |
| 43 | protein localization to Golgi apparatus (GO:0034067) | 3.41971912 |
| 44 | negative regulation of neurotransmitter secretion (GO:0046929) | 3.37256367 |
| 45 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.35407328 |
| 46 | chaperone-mediated protein transport (GO:0072321) | 3.31854913 |
| 47 | catecholamine biosynthetic process (GO:0042423) | 3.30596683 |
| 48 | catechol-containing compound biosynthetic process (GO:0009713) | 3.30596683 |
| 49 | activated T cell proliferation (GO:0050798) | 3.24812883 |
| 50 | cholesterol biosynthetic process (GO:0006695) | 3.24176070 |
| 51 | cellular response to ethanol (GO:0071361) | 3.22579666 |
| 52 | regulation of protein kinase A signaling (GO:0010738) | 3.20913255 |
| 53 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.20905229 |
| 54 | axonal fasciculation (GO:0007413) | 3.20370408 |
| 55 | phenol-containing compound catabolic process (GO:0019336) | 3.20181088 |
| 56 | response to pheromone (GO:0019236) | 3.17587191 |
| 57 | interkinetic nuclear migration (GO:0022027) | 3.17238011 |
| 58 | regulation of pigment cell differentiation (GO:0050932) | 3.14550060 |
| 59 | neuronal action potential propagation (GO:0019227) | 3.14258636 |
| 60 | vocalization behavior (GO:0071625) | 3.13869257 |
| 61 | cellular response to epinephrine stimulus (GO:0071872) | 3.13621723 |
| 62 | L-fucose catabolic process (GO:0042355) | 3.13378052 |
| 63 | fucose catabolic process (GO:0019317) | 3.13378052 |
| 64 | L-fucose metabolic process (GO:0042354) | 3.13378052 |
| 65 | glutamate receptor signaling pathway (GO:0007215) | 3.13238847 |
| 66 | negative regulation of translation, ncRNA-mediated (GO:0040033) | 3.11227480 |
| 67 | regulation of translation, ncRNA-mediated (GO:0045974) | 3.11227480 |
| 68 | negative regulation of translation involved in gene silencing by miRNA (GO:0035278) | 3.11227480 |
| 69 | catecholamine transport (GO:0051937) | 3.09613572 |
| 70 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.03754659 |
| 71 | response to redox state (GO:0051775) | 3.03662076 |
| 72 | histone H3-K4 trimethylation (GO:0080182) | 3.02908413 |
| 73 | regulation of collateral sprouting (GO:0048670) | 3.02280478 |
| 74 | positive regulation of developmental pigmentation (GO:0048087) | 2.99297167 |
| 75 | synaptic vesicle exocytosis (GO:0016079) | 2.98191799 |
| 76 | response to methylmercury (GO:0051597) | 2.97194750 |
| 77 | negative regulation of protein localization to cell surface (GO:2000009) | 2.97116194 |
| 78 | negative regulation of peptidyl-threonine phosphorylation (GO:0010801) | 2.96249037 |
| 79 | regulation of vesicle fusion (GO:0031338) | 2.95625412 |
| 80 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.94560801 |
| 81 | response to epinephrine (GO:0071871) | 2.93260379 |
| 82 | positive regulation of granulocyte differentiation (GO:0030854) | 2.92169884 |
| 83 | inner mitochondrial membrane organization (GO:0007007) | 2.91985838 |
| 84 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.91710743 |
| 85 | hydrogen ion transmembrane transport (GO:1902600) | 2.89907267 |
| 86 | regulation of protein glycosylation (GO:0060049) | 2.86413494 |
| 87 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.85221338 |
| 88 | cilium or flagellum-dependent cell motility (GO:0001539) | 2.85124223 |
| 89 | protein localization to synapse (GO:0035418) | 2.85025643 |
| 90 | cellular ketone body metabolic process (GO:0046950) | 2.84691257 |
| 91 | axoneme assembly (GO:0035082) | 2.84597321 |
| 92 | neuron-neuron synaptic transmission (GO:0007270) | 2.82073694 |
| 93 | regulation of synapse assembly (GO:0051963) | 2.81470516 |
| 94 | neurotransmitter biosynthetic process (GO:0042136) | 2.80628213 |
| 95 | sterol biosynthetic process (GO:0016126) | 2.80530724 |
| 96 | regulation of establishment of cell polarity (GO:2000114) | 2.80240887 |
| 97 | photoreceptor cell maintenance (GO:0045494) | 2.76912650 |
| 98 | response to cocaine (GO:0042220) | 2.76796946 |
| 99 | regulation of glutamate secretion (GO:0014048) | 2.76046040 |
| 100 | isoprenoid biosynthetic process (GO:0008299) | 2.75992024 |
| 101 | dendritic spine morphogenesis (GO:0060997) | 2.75867507 |
| 102 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 2.75526260 |
| 103 | detection of light stimulus involved in visual perception (GO:0050908) | 2.74786230 |
| 104 | detection of light stimulus involved in sensory perception (GO:0050962) | 2.74786230 |
| 105 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.74021621 |
| 106 | regulation of glucokinase activity (GO:0033131) | 2.72996309 |
| 107 | regulation of hexokinase activity (GO:1903299) | 2.72996309 |
| 108 | adult walking behavior (GO:0007628) | 2.72731874 |
| 109 | postsynaptic membrane organization (GO:0001941) | 2.71472697 |
| 110 | response to histamine (GO:0034776) | 2.70892029 |
| 111 | synapse assembly (GO:0007416) | 2.70558634 |
| 112 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 2.70096469 |
| 113 | proton transport (GO:0015992) | 2.69872672 |
| 114 | behavioral response to cocaine (GO:0048148) | 2.69517958 |
| 115 | negative regulation of axon extension (GO:0030517) | 2.68991121 |
| 116 | dopamine metabolic process (GO:0042417) | 2.68975465 |
| 117 | calcium-mediated signaling using intracellular calcium source (GO:0035584) | 2.68611647 |
| 118 | histone H2B ubiquitination (GO:0033523) | 2.66203033 |
| 119 | protein K63-linked deubiquitination (GO:0070536) | 2.65295268 |
| 120 | signal peptide processing (GO:0006465) | 2.64862717 |
| 121 | oligodendrocyte differentiation (GO:0048709) | 2.64485426 |
| 122 | kidney morphogenesis (GO:0060993) | 2.64476490 |
| 123 | epithelial cilium movement (GO:0003351) | 2.64470313 |
| 124 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.63549744 |
| 125 | alkaloid metabolic process (GO:0009820) | 2.63338599 |
| 126 | hydrogen transport (GO:0006818) | 2.63188963 |
| 127 | indolalkylamine metabolic process (GO:0006586) | 2.62417117 |
| 128 | intra-Golgi vesicle-mediated transport (GO:0006891) | 2.61942690 |
| 129 | regulation of feeding behavior (GO:0060259) | 2.60074846 |
| 130 | peptidyl-lysine trimethylation (GO:0018023) | 2.59376394 |
| 131 | ATP hydrolysis coupled proton transport (GO:0015991) | 2.56956528 |
| 132 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 2.56956528 |
| 133 | membrane hyperpolarization (GO:0060081) | 2.56708081 |
| 134 | limb bud formation (GO:0060174) | 2.56395098 |
| 135 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.55952482 |
| 136 | neural nucleus development (GO:0048857) | 2.55293406 |
| 137 | negative regulation of synaptic transmission (GO:0050805) | 2.55286020 |
| 138 | GTP biosynthetic process (GO:0006183) | 2.55172181 |
| 139 | ketone body metabolic process (GO:1902224) | 2.54495629 |
| 140 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 2.54491431 |
| 141 | cilium movement (GO:0003341) | 2.54013710 |
| 142 | synaptic transmission, glutamatergic (GO:0035249) | 2.53611826 |
| 143 | protein targeting to vacuole (GO:0006623) | 2.53187020 |
| 144 | protein targeting to lysosome (GO:0006622) | 2.53187020 |
| 145 | establishment of protein localization to vacuole (GO:0072666) | 2.53187020 |
| 146 | protein K48-linked deubiquitination (GO:0071108) | 2.53139156 |
| 147 | Golgi to endosome transport (GO:0006895) | 2.52597878 |
| 148 | amyloid precursor protein metabolic process (GO:0042982) | 2.51000593 |
| 149 | cilium organization (GO:0044782) | 2.50983725 |
| 150 | neuronal ion channel clustering (GO:0045161) | 2.50557641 |
| 151 | early endosome to late endosome transport (GO:0045022) | 2.50134335 |
| 152 | cilium morphogenesis (GO:0060271) | 2.50124086 |
| 153 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.49667324 |
| 154 | protein localization to cilium (GO:0061512) | 2.49136642 |
| 155 | histone mRNA catabolic process (GO:0071044) | 2.49125612 |
| 156 | inositol phosphate catabolic process (GO:0071545) | 2.48957888 |
| 157 | dendrite development (GO:0016358) | 2.48619985 |
| 158 | locomotory exploration behavior (GO:0035641) | 2.48358382 |
| 159 | membrane assembly (GO:0071709) | 2.46547030 |
| 160 | cilium assembly (GO:0042384) | 2.46506931 |
| 161 | polyol catabolic process (GO:0046174) | 2.44611233 |
| 162 | indole-containing compound catabolic process (GO:0042436) | 2.40891929 |
| 163 | indolalkylamine catabolic process (GO:0046218) | 2.40891929 |
| 164 | tryptophan catabolic process (GO:0006569) | 2.40891929 |
| 165 | dentate gyrus development (GO:0021542) | 2.38564301 |
| 166 | cAMP catabolic process (GO:0006198) | 2.38525963 |
| 167 | regulation of establishment or maintenance of cell polarity (GO:0032878) | 2.36373354 |
| 168 | positive regulation of glycolytic process (GO:0045821) | 2.34384466 |
| 169 | reflex (GO:0060004) | 2.34016162 |
| 170 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.33413872 |
| 171 | cyclic nucleotide catabolic process (GO:0009214) | 2.33122141 |
| 172 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.33095866 |
| 173 | regulation of memory T cell differentiation (GO:0043380) | 2.29212259 |
| 174 | phospholipid translocation (GO:0045332) | 2.29082958 |
| 175 | lipid translocation (GO:0034204) | 2.29082958 |
| 176 | phospholipid homeostasis (GO:0055091) | 2.27762361 |
| 177 | nucleus localization (GO:0051647) | 2.26857226 |
| 178 | regulation of sarcomere organization (GO:0060297) | 2.25372307 |
| 179 | tryptophan metabolic process (GO:0006568) | 2.25286403 |
| 180 | negative regulation of calcium ion-dependent exocytosis (GO:0045955) | 2.24785448 |
| 181 | macroautophagy (GO:0016236) | 2.24153352 |
| 182 | regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211) | 2.23770552 |
| 183 | positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213) | 2.23770552 |
| 184 | positive regulation of mRNA catabolic process (GO:0061014) | 2.23414847 |
| 185 | regulation of relaxation of muscle (GO:1901077) | 2.22493560 |
| 186 | interferon-gamma production (GO:0032609) | 2.21748520 |
| 187 | histone H3-K9 methylation (GO:0051567) | 2.20617324 |
| 188 | negative regulation of complement activation (GO:0045916) | 2.19063170 |
| 189 | positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO | 2.18679998 |
| 190 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151) | 2.18679998 |
| 191 | embryonic epithelial tube formation (GO:0001838) | 2.18328471 |
| 192 | regulation of MHC class I biosynthetic process (GO:0045343) | 2.18156959 |
| 193 | regulation of ER to Golgi vesicle-mediated transport (GO:0060628) | 2.17446501 |
| 194 | behavioral response to nicotine (GO:0035095) | 2.16645481 |
| 195 | prostate gland growth (GO:0060736) | 2.16495285 |
| 196 | intraciliary transport (GO:0042073) | 2.16209249 |
| 197 | phosphorylated carbohydrate dephosphorylation (GO:0046838) | 2.15627440 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.75607611 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.66151239 |
| 3 | TAF15_26573619_Chip-Seq_HEK293_Human | 3.62242514 |
| 4 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 3.02832462 |
| 5 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.65117933 |
| 6 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.59708874 |
| 7 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.47619855 |
| 8 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.46024634 |
| 9 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 2.38711566 |
| 10 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.33880546 |
| 11 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.21155361 |
| 12 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.21096788 |
| 13 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.18230343 |
| 14 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 2.14916908 |
| 15 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.13231956 |
| 16 | FUS_26573619_Chip-Seq_HEK293_Human | 2.12537000 |
| 17 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.10800137 |
| 18 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.07031829 |
| 19 | VDR_22108803_ChIP-Seq_LS180_Human | 2.06696161 |
| 20 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.05509501 |
| 21 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.04947885 |
| 22 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.02150126 |
| 23 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.01775962 |
| 24 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.01775962 |
| 25 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.99120917 |
| 26 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.98251699 |
| 27 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.98186664 |
| 28 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.97438886 |
| 29 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.96020289 |
| 30 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.95797718 |
| 31 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.95022246 |
| 32 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.91198180 |
| 33 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.90434059 |
| 34 | P300_19829295_ChIP-Seq_ESCs_Human | 1.88869698 |
| 35 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.88695295 |
| 36 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.85751524 |
| 37 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.82192699 |
| 38 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.78112596 |
| 39 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.77349922 |
| 40 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.75597349 |
| 41 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.74553442 |
| 42 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.73520621 |
| 43 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.72572293 |
| 44 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.72095251 |
| 45 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.72032011 |
| 46 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.71298827 |
| 47 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.64860348 |
| 48 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.61062757 |
| 49 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.59691156 |
| 50 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.57510739 |
| 51 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.55043203 |
| 52 | * SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.54253724 |
| 53 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.53808068 |
| 54 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.50737796 |
| 55 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.49176154 |
| 56 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.49176154 |
| 57 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.48943342 |
| 58 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.48865282 |
| 59 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.47505532 |
| 60 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.46560936 |
| 61 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.46360906 |
| 62 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.46192438 |
| 63 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.43737823 |
| 64 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.43118510 |
| 65 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.41130638 |
| 66 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.40533996 |
| 67 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.40517660 |
| 68 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.38931329 |
| 69 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.36369113 |
| 70 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.33174112 |
| 71 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.32349257 |
| 72 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.31977973 |
| 73 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.31159733 |
| 74 | EWS_26573619_Chip-Seq_HEK293_Human | 1.30929691 |
| 75 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.30697035 |
| 76 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.30536424 |
| 77 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.30285176 |
| 78 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.29739947 |
| 79 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.29523768 |
| 80 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.28384224 |
| 81 | TP53_16413492_ChIP-PET_HCT116_Human | 1.25381365 |
| 82 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.24411799 |
| 83 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.24119350 |
| 84 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.23502249 |
| 85 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.23482323 |
| 86 | * NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.23475217 |
| 87 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.23387375 |
| 88 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.22279757 |
| 89 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.21460239 |
| 90 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.20257196 |
| 91 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.19557039 |
| 92 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.17093116 |
| 93 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.16665792 |
| 94 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.16396087 |
| 95 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.16357866 |
| 96 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.16256951 |
| 97 | JUN_21703547_ChIP-Seq_K562_Human | 1.15619885 |
| 98 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.15506024 |
| 99 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.15030682 |
| 100 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.14650130 |
| 101 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.14461858 |
| 102 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.14059331 |
| 103 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.14038939 |
| 104 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.13775910 |
| 105 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.13709016 |
| 106 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.13625169 |
| 107 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.13401690 |
| 108 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.13233494 |
| 109 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.12173683 |
| 110 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.12173683 |
| 111 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.12027514 |
| 112 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 1.11761142 |
| 113 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.11068489 |
| 114 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.10966355 |
| 115 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.10835432 |
| 116 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.09880653 |
| 117 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.09051468 |
| 118 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.08948224 |
| 119 | TCF4_23295773_ChIP-Seq_U87_Human | 1.08933580 |
| 120 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.08426391 |
| 121 | * KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.08378850 |
| 122 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.08081062 |
| 123 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.05612563 |
| 124 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.04901092 |
| 125 | * SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.04878165 |
| 126 | STAT3_23295773_ChIP-Seq_U87_Human | 1.04012606 |
| 127 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.03456080 |
| 128 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.03456080 |
| 129 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.03354104 |
| 130 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.03354104 |
| 131 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.03063287 |
| 132 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.03045205 |
| 133 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.02961886 |
| 134 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.02487803 |
| 135 | * AR_25329375_ChIP-Seq_VCAP_Human | 1.02254513 |
| 136 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 1.02126567 |
| 137 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.00732022 |
| 138 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.00583068 |
| 139 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.00079305 |
| 140 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.00012588 |
| 141 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.99389052 |
| 142 | KDM2B_26808549_Chip-Seq_REH_Human | 0.98855859 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003880_abnormal_central_pattern | 6.16281436 |
| 2 | MP0000569_abnormal_digit_pigmentation | 5.25912784 |
| 3 | MP0001529_abnormal_vocalization | 4.01741390 |
| 4 | MP0003787_abnormal_imprinting | 3.68944788 |
| 5 | MP0001905_abnormal_dopamine_level | 3.37146570 |
| 6 | MP0006276_abnormal_autonomic_nervous | 3.34974176 |
| 7 | MP0005409_darkened_coat_color | 3.11273352 |
| 8 | MP0008877_abnormal_DNA_methylation | 2.99427844 |
| 9 | MP0003195_calcinosis | 2.87042236 |
| 10 | MP0002064_seizures | 2.76417787 |
| 11 | MP0004859_abnormal_synaptic_plasticity | 2.70063024 |
| 12 | MP0003635_abnormal_synaptic_transmissio | 2.66656869 |
| 13 | MP0004270_analgesia | 2.65827185 |
| 14 | MP0005423_abnormal_somatic_nervous | 2.64506172 |
| 15 | MP0009745_abnormal_behavioral_response | 2.58855623 |
| 16 | MP0001440_abnormal_grooming_behavior | 2.51114052 |
| 17 | MP0009379_abnormal_foot_pigmentation | 2.50210276 |
| 18 | MP0001486_abnormal_startle_reflex | 2.45058796 |
| 19 | MP0002272_abnormal_nervous_system | 2.40141934 |
| 20 | MP0009046_muscle_twitch | 2.39808385 |
| 21 | MP0000920_abnormal_myelination | 2.36686977 |
| 22 | MP0004742_abnormal_vestibular_system | 2.31947943 |
| 23 | MP0004043_abnormal_pH_regulation | 2.30657863 |
| 24 | MP0002572_abnormal_emotion/affect_behav | 2.28564518 |
| 25 | MP0005174_abnormal_tail_pigmentation | 2.25524534 |
| 26 | MP0002822_catalepsy | 2.25457949 |
| 27 | MP0001968_abnormal_touch/_nociception | 2.14679388 |
| 28 | MP0000778_abnormal_nervous_system | 2.12797383 |
| 29 | MP0003646_muscle_fatigue | 2.12640698 |
| 30 | MP0001188_hyperpigmentation | 2.11084812 |
| 31 | MP0004142_abnormal_muscle_tone | 2.09805337 |
| 32 | MP0000427_abnormal_hair_cycle | 2.07849406 |
| 33 | MP0008057_abnormal_DNA_replication | 2.01845124 |
| 34 | MP0002063_abnormal_learning/memory/cond | 2.00900538 |
| 35 | MP0002734_abnormal_mechanical_nocicepti | 1.95774995 |
| 36 | MP0001501_abnormal_sleep_pattern | 1.89948650 |
| 37 | MP0005075_abnormal_melanosome_morpholog | 1.88761333 |
| 38 | MP0002736_abnormal_nociception_after | 1.83253722 |
| 39 | MP0004924_abnormal_behavior | 1.82614263 |
| 40 | MP0005386_behavior/neurological_phenoty | 1.82614263 |
| 41 | MP0002009_preneoplasia | 1.81073402 |
| 42 | MP0002735_abnormal_chemical_nociception | 1.77508590 |
| 43 | MP0002067_abnormal_sensory_capabilities | 1.77107938 |
| 44 | MP0005171_absent_coat_pigmentation | 1.73221248 |
| 45 | MP0002733_abnormal_thermal_nociception | 1.70956778 |
| 46 | MP0001970_abnormal_pain_threshold | 1.66297031 |
| 47 | MP0002184_abnormal_innervation | 1.62848780 |
| 48 | MP0002928_abnormal_bile_duct | 1.60731091 |
| 49 | MP0006054_spinal_hemorrhage | 1.56284860 |
| 50 | MP0003724_increased_susceptibility_to | 1.51912872 |
| 51 | MP0002557_abnormal_social/conspecific_i | 1.51552253 |
| 52 | MP0005551_abnormal_eye_electrophysiolog | 1.48250142 |
| 53 | MP0000383_abnormal_hair_follicle | 1.48099093 |
| 54 | MP0003136_yellow_coat_color | 1.48006277 |
| 55 | MP0003329_amyloid_beta_deposits | 1.47543789 |
| 56 | MP0001986_abnormal_taste_sensitivity | 1.46397415 |
| 57 | MP0003122_maternal_imprinting | 1.45832764 |
| 58 | MP0002166_altered_tumor_susceptibility | 1.42636907 |
| 59 | MP0001835_abnormal_antigen_presentation | 1.41322389 |
| 60 | MP0003252_abnormal_bile_duct | 1.38324557 |
| 61 | MP0005379_endocrine/exocrine_gland_phen | 1.37338244 |
| 62 | MP0004484_altered_response_of | 1.34365148 |
| 63 | MP0004215_abnormal_myocardial_fiber | 1.34249479 |
| 64 | MP0003121_genomic_imprinting | 1.34082839 |
| 65 | MP0000462_abnormal_digestive_system | 1.33731587 |
| 66 | MP0004145_abnormal_muscle_electrophysio | 1.30854696 |
| 67 | MP0004885_abnormal_endolymph | 1.30615921 |
| 68 | MP0002882_abnormal_neuron_morphology | 1.29938395 |
| 69 | MP0005410_abnormal_fertilization | 1.29510768 |
| 70 | MP0006072_abnormal_retinal_apoptosis | 1.29093636 |
| 71 | MP0003690_abnormal_glial_cell | 1.27623948 |
| 72 | MP0002066_abnormal_motor_capabilities/c | 1.26762704 |
| 73 | MP0000955_abnormal_spinal_cord | 1.25556710 |
| 74 | MP0003045_fibrosis | 1.24999554 |
| 75 | MP0001485_abnormal_pinna_reflex | 1.24244054 |
| 76 | MP0003634_abnormal_glial_cell | 1.24104472 |
| 77 | MP0000015_abnormal_ear_pigmentation | 1.22765354 |
| 78 | MP0005310_abnormal_salivary_gland | 1.21675360 |
| 79 | MP0002229_neurodegeneration | 1.20759626 |
| 80 | MP0001984_abnormal_olfaction | 1.19773135 |
| 81 | MP0002396_abnormal_hematopoietic_system | 1.17113984 |
| 82 | MP0001963_abnormal_hearing_physiology | 1.14793169 |
| 83 | MP0002752_abnormal_somatic_nervous | 1.13776783 |
| 84 | MP0003632_abnormal_nervous_system | 1.09544872 |
| 85 | MP0003763_abnormal_thymus_physiology | 1.08703960 |
| 86 | MP0010678_abnormal_skin_adnexa | 1.08206684 |
| 87 | MP0002693_abnormal_pancreas_physiology | 1.07967505 |
| 88 | MP0001800_abnormal_humoral_immune | 1.07482994 |
| 89 | MP0008995_early_reproductive_senescence | 1.04276992 |
| 90 | MP0002095_abnormal_skin_pigmentation | 1.02737515 |
| 91 | MP0004130_abnormal_muscle_cell | 1.02087972 |
| 92 | MP0000631_abnormal_neuroendocrine_gland | 1.01649147 |
| 93 | MP0001502_abnormal_circadian_rhythm | 1.00530905 |
| 94 | MP0002102_abnormal_ear_morphology | 0.99069921 |
| 95 | MP0002909_abnormal_adrenal_gland | 0.97037547 |
| 96 | MP0002163_abnormal_gland_morphology | 0.95468718 |
| 97 | MP0005646_abnormal_pituitary_gland | 0.94697649 |
| 98 | MP0005645_abnormal_hypothalamus_physiol | 0.94676375 |
| 99 | MP0000026_abnormal_inner_ear | 0.92519412 |
| 100 | MP0002168_other_aberrant_phenotype | 0.92312853 |
| 101 | MP0002152_abnormal_brain_morphology | 0.91551677 |
| 102 | MP0005671_abnormal_response_to | 0.91425913 |
| 103 | MP0003631_nervous_system_phenotype | 0.89715087 |
| 104 | MP0003938_abnormal_ear_development | 0.89482598 |
| 105 | MP0002876_abnormal_thyroid_physiology | 0.88738219 |
| 106 | MP0002938_white_spotting | 0.88537695 |
| 107 | MP0000371_diluted_coat_color | 0.88250740 |
| 108 | MP0002837_dystrophic_cardiac_calcinosis | 0.87838221 |
| 109 | MP0000013_abnormal_adipose_tissue | 0.87768698 |
| 110 | MP0001664_abnormal_digestion | 0.86927728 |
| 111 | MP0005253_abnormal_eye_physiology | 0.85921780 |
| 112 | MP0005220_abnormal_exocrine_pancreas | 0.85919507 |
| 113 | MP0008569_lethality_at_weaning | 0.85195755 |
| 114 | MP0008872_abnormal_physiological_respon | 0.84255455 |
| 115 | MP0000230_abnormal_systemic_arterial | 0.83640859 |
| 116 | MP0004147_increased_porphyrin_level | 0.83447719 |
| 117 | MP0003656_abnormal_erythrocyte_physiolo | 0.83369655 |
| 118 | MP0005266_abnormal_metabolism | 0.80244185 |
| 119 | MP0003011_delayed_dark_adaptation | 0.79587519 |
| 120 | MP0005195_abnormal_posterior_eye | 0.79318738 |
| 121 | MP0001756_abnormal_urination | 0.78733900 |
| 122 | MP0010329_abnormal_lipoprotein_level | 0.78375314 |
| 123 | MP0003890_abnormal_embryonic-extraembry | 0.77979227 |
| 124 | MP0009780_abnormal_chondrocyte_physiolo | 0.77722245 |
| 125 | MP0004381_abnormal_hair_follicle | 0.77477307 |
| 126 | MP0003866_abnormal_defecation | 0.77266945 |
| 127 | MP0002006_tumorigenesis | 0.76801074 |
| 128 | MP0004084_abnormal_cardiac_muscle | 0.75210318 |
| 129 | MP0005367_renal/urinary_system_phenotyp | 0.74141348 |
| 130 | MP0000516_abnormal_urinary_system | 0.74141348 |
| 131 | MP0002078_abnormal_glucose_homeostasis | 0.73560874 |
| 132 | MP0005389_reproductive_system_phenotype | 0.73560152 |
| 133 | MP0002751_abnormal_autonomic_nervous | 0.73502521 |
| 134 | MP0005535_abnormal_body_temperature | 0.73067822 |
| 135 | MP0000372_irregular_coat_pigmentation | 0.72022721 |
| 136 | MP0001661_extended_life_span | 0.71825186 |
| 137 | MP0008775_abnormal_heart_ventricle | 0.71640790 |
| 138 | MP0005167_abnormal_blood-brain_barrier | 0.70526611 |
| 139 | MP0010386_abnormal_urinary_bladder | 0.70215157 |
| 140 | MP0003633_abnormal_nervous_system | 0.69406785 |
| 141 | MP0001324_abnormal_eye_pigmentation | 0.68900946 |
| 142 | MP0004811_abnormal_neuron_physiology | 0.68684983 |
| 143 | MP0003137_abnormal_impulse_conducting | 0.67488447 |
| 144 | MP0002090_abnormal_vision | 0.65531222 |
| 145 | MP0001299_abnormal_eye_distance/ | 0.64221392 |
| 146 | MP0001727_abnormal_embryo_implantation | 0.63909730 |
| 147 | MP0002069_abnormal_eating/drinking_beha | 0.63302514 |
| 148 | MP0001943_abnormal_respiration | 0.63127967 |
| 149 | MP0002638_abnormal_pupillary_reflex | 0.60714114 |
| 150 | MP0004085_abnormal_heartbeat | 0.59237488 |
| 151 | MP0005394_taste/olfaction_phenotype | 0.58809538 |
| 152 | MP0005499_abnormal_olfactory_system | 0.58809538 |
| 153 | MP0000747_muscle_weakness | 0.57548476 |
| 154 | MP0001346_abnormal_lacrimal_gland | 0.57424216 |
| 155 | MP0003950_abnormal_plasma_membrane | 0.56907922 |
| 156 | MP0001340_abnormal_eyelid_morphology | 0.55968078 |
| 157 | MP0002332_abnormal_exercise_endurance | 0.55167725 |
| 158 | MP0001177_atelectasis | 0.53991743 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Acute necrotizing encephalopathy (HP:0006965) | 4.57226809 |
| 2 | Limb dystonia (HP:0002451) | 4.30349895 |
| 3 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 4.22186355 |
| 4 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 4.22186355 |
| 5 | Pancreatic cysts (HP:0001737) | 4.15042603 |
| 6 | Neurofibrillary tangles (HP:0002185) | 4.06850522 |
| 7 | Sensory axonal neuropathy (HP:0003390) | 4.01040544 |
| 8 | Progressive macrocephaly (HP:0004481) | 3.95338129 |
| 9 | Abnormality of the renal cortex (HP:0011035) | 3.92694866 |
| 10 | Mitochondrial inheritance (HP:0001427) | 3.91896560 |
| 11 | Increased hepatocellular lipid droplets (HP:0006565) | 3.79399546 |
| 12 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.78458031 |
| 13 | Pancreatic fibrosis (HP:0100732) | 3.64558805 |
| 14 | Renal Fanconi syndrome (HP:0001994) | 3.59328770 |
| 15 | True hermaphroditism (HP:0010459) | 3.52970562 |
| 16 | Parakeratosis (HP:0001036) | 3.50071431 |
| 17 | Nephronophthisis (HP:0000090) | 3.49319642 |
| 18 | Cerebral inclusion bodies (HP:0100314) | 3.45658692 |
| 19 | Acute encephalopathy (HP:0006846) | 3.45599195 |
| 20 | Gaze-evoked nystagmus (HP:0000640) | 3.44201482 |
| 21 | Abnormality of the renal medulla (HP:0100957) | 3.35160658 |
| 22 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 3.34047265 |
| 23 | Molar tooth sign on MRI (HP:0002419) | 3.26782025 |
| 24 | Abnormality of midbrain morphology (HP:0002418) | 3.26782025 |
| 25 | Peripheral hypomyelination (HP:0007182) | 3.22959467 |
| 26 | Atonic seizures (HP:0010819) | 3.22655614 |
| 27 | Focal motor seizures (HP:0011153) | 3.22288474 |
| 28 | Thyroiditis (HP:0100646) | 3.21630617 |
| 29 | Abnormality of the corticospinal tract (HP:0002492) | 3.20707210 |
| 30 | Chronic hepatic failure (HP:0100626) | 3.15694970 |
| 31 | Myokymia (HP:0002411) | 3.15630468 |
| 32 | Lipid accumulation in hepatocytes (HP:0006561) | 3.09386207 |
| 33 | Genetic anticipation (HP:0003743) | 3.08064228 |
| 34 | Renal cortical cysts (HP:0000803) | 3.06393834 |
| 35 | Optic disc pallor (HP:0000543) | 3.01142065 |
| 36 | Leukodystrophy (HP:0002415) | 3.00908400 |
| 37 | Hypothermia (HP:0002045) | 3.00903366 |
| 38 | Pheochromocytoma (HP:0002666) | 2.98860857 |
| 39 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.96873138 |
| 40 | Increased CSF lactate (HP:0002490) | 2.95332214 |
| 41 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.92704384 |
| 42 | Focal seizures (HP:0007359) | 2.85159456 |
| 43 | Cerebral hemorrhage (HP:0001342) | 2.82739713 |
| 44 | Progressive cerebellar ataxia (HP:0002073) | 2.82712958 |
| 45 | Abnormal ciliary motility (HP:0012262) | 2.82198808 |
| 46 | Fair hair (HP:0002286) | 2.79089518 |
| 47 | Neuroendocrine neoplasm (HP:0100634) | 2.74005126 |
| 48 | Stomatitis (HP:0010280) | 2.73490753 |
| 49 | Hepatocellular necrosis (HP:0001404) | 2.71097922 |
| 50 | Protruding tongue (HP:0010808) | 2.70901196 |
| 51 | Absent/shortened dynein arms (HP:0200106) | 2.70846944 |
| 52 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.70846944 |
| 53 | Volvulus (HP:0002580) | 2.67715700 |
| 54 | Retinal dysplasia (HP:0007973) | 2.60513491 |
| 55 | Abnormal pupillary function (HP:0007686) | 2.54869513 |
| 56 | Broad-based gait (HP:0002136) | 2.53711337 |
| 57 | Attenuation of retinal blood vessels (HP:0007843) | 2.50073209 |
| 58 | Vaginal atresia (HP:0000148) | 2.48607192 |
| 59 | Tubular atrophy (HP:0000092) | 2.48560052 |
| 60 | Stomach cancer (HP:0012126) | 2.46702555 |
| 61 | Genital tract atresia (HP:0001827) | 2.46276378 |
| 62 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.44891813 |
| 63 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.44891813 |
| 64 | Hematochezia (HP:0002573) | 2.44856310 |
| 65 | Congenital stationary night blindness (HP:0007642) | 2.44476159 |
| 66 | Polydipsia (HP:0001959) | 2.44277092 |
| 67 | Abnormal drinking behavior (HP:0030082) | 2.44277092 |
| 68 | Cystic liver disease (HP:0006706) | 2.41896383 |
| 69 | Abnormality of renal resorption (HP:0011038) | 2.38324896 |
| 70 | Abnormal biliary tract physiology (HP:0012439) | 2.36291016 |
| 71 | Bile duct proliferation (HP:0001408) | 2.36291016 |
| 72 | Abolished electroretinogram (ERG) (HP:0000550) | 2.35200582 |
| 73 | Decreased circulating renin level (HP:0003351) | 2.33929567 |
| 74 | Abnormal respiratory motile cilium physiology (HP:0012261) | 2.32972779 |
| 75 | Abnormality of the parathyroid morphology (HP:0011766) | 2.32733916 |
| 76 | Dialeptic seizures (HP:0011146) | 2.31978442 |
| 77 | Dysmetria (HP:0001310) | 2.31033020 |
| 78 | Large for gestational age (HP:0001520) | 2.29271081 |
| 79 | 3-Methylglutaconic aciduria (HP:0003535) | 2.27459259 |
| 80 | Absence seizures (HP:0002121) | 2.27122123 |
| 81 | Epileptic encephalopathy (HP:0200134) | 2.27096647 |
| 82 | Hyperventilation (HP:0002883) | 2.26551720 |
| 83 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 2.26307050 |
| 84 | Gait imbalance (HP:0002141) | 2.25523507 |
| 85 | T lymphocytopenia (HP:0005403) | 2.25317327 |
| 86 | Cerebral edema (HP:0002181) | 2.23035084 |
| 87 | Medial flaring of the eyebrow (HP:0010747) | 2.22463575 |
| 88 | Increased intramyocellular lipid droplets (HP:0012240) | 2.22299794 |
| 89 | Generalized hypopigmentation of hair (HP:0011358) | 2.22003007 |
| 90 | Abnormality of T cell number (HP:0011839) | 2.21951908 |
| 91 | Febrile seizures (HP:0002373) | 2.21441408 |
| 92 | Insidious onset (HP:0003587) | 2.16163653 |
| 93 | Termporal pattern (HP:0011008) | 2.16163653 |
| 94 | Congenital hepatic fibrosis (HP:0002612) | 2.15315788 |
| 95 | Intestinal atresia (HP:0011100) | 2.14997315 |
| 96 | Congenital ichthyosiform erythroderma (HP:0007431) | 2.12844621 |
| 97 | Furrowed tongue (HP:0000221) | 2.12595799 |
| 98 | Visual hallucinations (HP:0002367) | 2.10903365 |
| 99 | Progressive inability to walk (HP:0002505) | 2.07936945 |
| 100 | Exertional dyspnea (HP:0002875) | 2.07644130 |
| 101 | Spastic gait (HP:0002064) | 2.06569556 |
| 102 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 2.05790410 |
| 103 | Abnormality of glycolysis (HP:0004366) | 2.03478342 |
| 104 | Increased serum pyruvate (HP:0003542) | 2.03478342 |
| 105 | Ketoacidosis (HP:0001993) | 2.03167845 |
| 106 | Hypochromic microcytic anemia (HP:0004840) | 2.02990844 |
| 107 | Respiratory failure (HP:0002878) | 2.02059691 |
| 108 | Infantile muscular hypotonia (HP:0008947) | 2.01775698 |
| 109 | Generalized tonic-clonic seizures (HP:0002069) | 2.01344650 |
| 110 | Congenital primary aphakia (HP:0007707) | 2.00603613 |
| 111 | Scanning speech (HP:0002168) | 2.00449677 |
| 112 | Anxiety (HP:0000739) | 2.00297804 |
| 113 | Supranuclear gaze palsy (HP:0000605) | 2.00287679 |
| 114 | Exercise intolerance (HP:0003546) | 2.00018018 |
| 115 | Alacrima (HP:0000522) | 1.98413129 |
| 116 | Cupped ear (HP:0000378) | 1.95715997 |
| 117 | Poor coordination (HP:0002370) | 1.95514302 |
| 118 | Overfolded helix (HP:0000396) | 1.94870031 |
| 119 | Abnormal hair whorl (HP:0010721) | 1.93683574 |
| 120 | Tubulointerstitial nephritis (HP:0001970) | 1.92571852 |
| 121 | Esotropia (HP:0000565) | 1.91084574 |
| 122 | X-linked dominant inheritance (HP:0001423) | 1.90899989 |
| 123 | Anomalous pulmonary venous return (HP:0010772) | 1.90575859 |
| 124 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.88653521 |
| 125 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.87982757 |
| 126 | Polyphagia (HP:0002591) | 1.87924066 |
| 127 | Hemiparesis (HP:0001269) | 1.87464063 |
| 128 | Retrobulbar optic neuritis (HP:0100654) | 1.87342109 |
| 129 | Optic neuritis (HP:0100653) | 1.87342109 |
| 130 | Akinesia (HP:0002304) | 1.85528248 |
| 131 | Male pseudohermaphroditism (HP:0000037) | 1.83557452 |
| 132 | Rimmed vacuoles (HP:0003805) | 1.83229346 |
| 133 | Tubulointerstitial abnormality (HP:0001969) | 1.82191405 |
| 134 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.81693322 |
| 135 | Recurrent cutaneous fungal infections (HP:0011370) | 1.81693322 |
| 136 | Abnormality of the axillary hair (HP:0100134) | 1.79767904 |
| 137 | Abnormality of secondary sexual hair (HP:0009888) | 1.79767904 |
| 138 | Postaxial foot polydactyly (HP:0001830) | 1.79735145 |
| 139 | Absent speech (HP:0001344) | 1.77869584 |
| 140 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.77727535 |
| 141 | Polyuria (HP:0000103) | 1.77635982 |
| 142 | Hypoplastic iliac wings (HP:0002866) | 1.77404398 |
| 143 | Papillary thyroid carcinoma (HP:0002895) | 1.76700073 |
| 144 | Nephrogenic diabetes insipidus (HP:0009806) | 1.76273951 |
| 145 | Inability to walk (HP:0002540) | 1.74867225 |
| 146 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.73769575 |
| 147 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.73520579 |
| 148 | Tented upper lip vermilion (HP:0010804) | 1.73434609 |
| 149 | Chin dimple (HP:0010751) | 1.72290285 |
| 150 | Widely spaced teeth (HP:0000687) | 1.72007633 |
| 151 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.71752601 |
| 152 | Drooling (HP:0002307) | 1.71468771 |
| 153 | Excessive salivation (HP:0003781) | 1.71468771 |
| 154 | Respiratory difficulties (HP:0002880) | 1.71121688 |
| 155 | Truncal obesity (HP:0001956) | 1.69732903 |
| 156 | Hepatic necrosis (HP:0002605) | 1.69123224 |
| 157 | Clumsiness (HP:0002312) | 1.68853394 |
| 158 | Hyperkalemia (HP:0002153) | 1.68826520 |
| 159 | Congenital sensorineural hearing impairment (HP:0008527) | 1.68771919 |
| 160 | Muscle hypertrophy of the lower extremities (HP:0008968) | 1.68108462 |
| 161 | Onion bulb formation (HP:0003383) | 1.67977238 |
| 162 | Abnormality of the pulmonary veins (HP:0011718) | 1.67772133 |
| 163 | Ketosis (HP:0001946) | 1.67106352 |
| 164 | Calf muscle hypertrophy (HP:0008981) | 1.66917718 |
| 165 | Facial diplegia (HP:0001349) | 1.65502983 |
| 166 | Neoplasm of the adrenal cortex (HP:0100641) | 1.65017216 |
| 167 | Severe combined immunodeficiency (HP:0004430) | 1.63446976 |
| 168 | Hypoproteinemia (HP:0003075) | 1.62227915 |
| 169 | Portal hypertension (HP:0001409) | 1.61365848 |
| 170 | Abnormality of vitamin B metabolism (HP:0004340) | 1.61267355 |
| 171 | Methylmalonic acidemia (HP:0002912) | 1.61197153 |
| 172 | Constricted visual fields (HP:0001133) | 1.60079849 |
| 173 | Hemiplegia (HP:0002301) | 1.58319293 |
| 174 | Blue irides (HP:0000635) | 1.58288766 |
| 175 | Chronic diarrhea (HP:0002028) | 1.58143311 |
| 176 | Hypoplastic ischia (HP:0003175) | 1.56816165 |
| 177 | Abnormal biliary tract morphology (HP:0012440) | 1.56555769 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FRK | 6.97529743 |
| 2 | PNCK | 4.15670472 |
| 3 | STK39 | 4.05639001 |
| 4 | ACVR1B | 3.18420478 |
| 5 | TNIK | 3.17774773 |
| 6 | CASK | 3.07072915 |
| 7 | MAP3K12 | 2.64382982 |
| 8 | OXSR1 | 2.63171790 |
| 9 | EPHA4 | 2.61406506 |
| 10 | TAOK3 | 2.57194780 |
| 11 | MAPKAPK5 | 2.44290086 |
| 12 | FES | 2.31040221 |
| 13 | AKT3 | 2.28077436 |
| 14 | MAP4K2 | 2.18110169 |
| 15 | MARK1 | 2.00421162 |
| 16 | NTRK3 | 1.92899198 |
| 17 | MAP3K4 | 1.89705886 |
| 18 | CSNK1G3 | 1.87814378 |
| 19 | GRK5 | 1.81901079 |
| 20 | NLK | 1.79299802 |
| 21 | NUAK1 | 1.77382366 |
| 22 | WNK4 | 1.77183024 |
| 23 | NME1 | 1.75027150 |
| 24 | BCR | 1.74614298 |
| 25 | TXK | 1.68009785 |
| 26 | PKN1 | 1.66539827 |
| 27 | FGR | 1.61587807 |
| 28 | MAP2K7 | 1.59155359 |
| 29 | MST4 | 1.57726776 |
| 30 | NTRK1 | 1.57174052 |
| 31 | TEC | 1.49552854 |
| 32 | CSNK1G2 | 1.49428235 |
| 33 | MAPK13 | 1.48693012 |
| 34 | TYRO3 | 1.47727374 |
| 35 | RIPK4 | 1.44980596 |
| 36 | GRK7 | 1.44547002 |
| 37 | CAMK2B | 1.43400644 |
| 38 | CSNK1G1 | 1.42465128 |
| 39 | SGK2 | 1.41877248 |
| 40 | UHMK1 | 1.40374750 |
| 41 | ERBB3 | 1.34805862 |
| 42 | OBSCN | 1.31860883 |
| 43 | MKNK2 | 1.28827660 |
| 44 | PBK | 1.27314588 |
| 45 | CAMK2D | 1.23295577 |
| 46 | PINK1 | 1.23064242 |
| 47 | CAMK2A | 1.21016756 |
| 48 | PIK3CG | 1.19730443 |
| 49 | BMPR1B | 1.19406398 |
| 50 | CAMKK2 | 1.17652531 |
| 51 | BMPR2 | 1.17142297 |
| 52 | ADRBK2 | 1.16582858 |
| 53 | CDK19 | 1.14805547 |
| 54 | LIMK1 | 1.13968891 |
| 55 | INSRR | 1.13699827 |
| 56 | CSNK1A1L | 1.11989702 |
| 57 | TRIM28 | 1.10605606 |
| 58 | NTRK2 | 1.10330607 |
| 59 | STK38L | 1.10318593 |
| 60 | MAP2K4 | 1.10209474 |
| 61 | FGFR3 | 1.09980245 |
| 62 | KIT | 1.07938197 |
| 63 | ARAF | 1.06739560 |
| 64 | MUSK | 1.04863380 |
| 65 | ROCK2 | 1.04113226 |
| 66 | DAPK2 | 1.02346424 |
| 67 | TRPM7 | 1.02052844 |
| 68 | IKBKE | 0.99797034 |
| 69 | EPHB1 | 0.99779220 |
| 70 | WNK1 | 0.98560274 |
| 71 | PLK2 | 0.97953826 |
| 72 | PIK3CA | 0.97281614 |
| 73 | ITK | 0.95033052 |
| 74 | EPHA3 | 0.92881242 |
| 75 | TNK2 | 0.92677358 |
| 76 | MAP2K6 | 0.90057034 |
| 77 | CDK5 | 0.89915570 |
| 78 | NEK6 | 0.89385833 |
| 79 | BLK | 0.87397776 |
| 80 | IRAK2 | 0.86921964 |
| 81 | JAK1 | 0.86580217 |
| 82 | FER | 0.85598892 |
| 83 | MINK1 | 0.85578237 |
| 84 | TGFBR1 | 0.83772498 |
| 85 | MAPK15 | 0.82970972 |
| 86 | MAP3K9 | 0.80724974 |
| 87 | PTK2B | 0.78901547 |
| 88 | CDK14 | 0.77447279 |
| 89 | SYK | 0.76993668 |
| 90 | MAP3K7 | 0.73012365 |
| 91 | PRKCE | 0.71603705 |
| 92 | ADRBK1 | 0.70538947 |
| 93 | STK3 | 0.70487834 |
| 94 | CAMK1G | 0.70391178 |
| 95 | DYRK2 | 0.69633880 |
| 96 | PRKCQ | 0.69406539 |
| 97 | STK16 | 0.68391024 |
| 98 | CAMK2G | 0.67921574 |
| 99 | FGFR2 | 0.67794106 |
| 100 | PRKAA2 | 0.67742576 |
| 101 | SGK3 | 0.67306934 |
| 102 | CDK15 | 0.66988651 |
| 103 | TYK2 | 0.64931453 |
| 104 | CDK18 | 0.64773442 |
| 105 | BRSK2 | 0.64096908 |
| 106 | BTK | 0.63211723 |
| 107 | EIF2AK3 | 0.62535333 |
| 108 | CDK11A | 0.60101111 |
| 109 | IRAK1 | 0.59052656 |
| 110 | MET | 0.58673285 |
| 111 | PRKACA | 0.56776779 |
| 112 | TLK1 | 0.56034238 |
| 113 | DYRK1A | 0.55872789 |
| 114 | STK11 | 0.55515845 |
| 115 | LCK | 0.53556458 |
| 116 | WNK3 | 0.53407538 |
| 117 | VRK1 | 0.52574380 |
| 118 | FYN | 0.51537334 |
| 119 | PRKCG | 0.50886515 |
| 120 | LYN | 0.50478824 |
| 121 | MAP3K2 | 0.49038846 |
| 122 | LATS1 | 0.48850095 |
| 123 | IKBKB | 0.48631861 |
| 124 | CSNK1E | 0.48076349 |
| 125 | ERBB4 | 0.47977864 |
| 126 | HCK | 0.47826401 |
| 127 | ZAK | 0.47504373 |
| 128 | MKNK1 | 0.46237240 |
| 129 | ERBB2 | 0.45039861 |
| 130 | JAK3 | 0.44922931 |
| 131 | MAP4K1 | 0.44338869 |
| 132 | PRKG1 | 0.43755298 |
| 133 | PAK3 | 0.42403574 |
| 134 | CHUK | 0.42370264 |
| 135 | RPS6KA5 | 0.42350642 |
| 136 | YES1 | 0.41846817 |
| 137 | RET | 0.41600281 |
| 138 | CSNK1A1 | 0.40540197 |
| 139 | PHKG2 | 0.40198126 |
| 140 | PHKG1 | 0.40198126 |
| 141 | MARK2 | 0.40064995 |
| 142 | CAMK4 | 0.39699971 |
| 143 | EGFR | 0.38860190 |
| 144 | MAP3K13 | 0.38791623 |
| 145 | MARK3 | 0.38484326 |
| 146 | CLK1 | 0.37849730 |
| 147 | GRK1 | 0.37576338 |
| 148 | PRKAA1 | 0.35163752 |
| 149 | GRK6 | 0.34816980 |
| 150 | SIK2 | 0.34323740 |
| 151 | ABL2 | 0.34160831 |
| 152 | SGK1 | 0.34064967 |
| 153 | CAMK1 | 0.33697129 |
| 154 | MYLK | 0.33066592 |
| 155 | BRD4 | 0.32873589 |
| 156 | MAP3K6 | 0.32869273 |
| 157 | CDK3 | 0.32758445 |
| 158 | SGK494 | 0.32656170 |
| 159 | SGK223 | 0.32656170 |
| 160 | PRKD2 | 0.32300037 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 4.81333546 |
| 2 | Parkinsons disease_Homo sapiens_hsa05012 | 3.90856917 |
| 3 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 3.44380665 |
| 4 | Alzheimers disease_Homo sapiens_hsa05010 | 3.30989597 |
| 5 | Nicotine addiction_Homo sapiens_hsa05033 | 3.00602707 |
| 6 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.69729131 |
| 7 | Huntingtons disease_Homo sapiens_hsa05016 | 2.65224146 |
| 8 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.42124372 |
| 9 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.27788620 |
| 10 | Steroid biosynthesis_Homo sapiens_hsa00100 | 2.26165525 |
| 11 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 2.23526553 |
| 12 | Serotonergic synapse_Homo sapiens_hsa04726 | 2.12930566 |
| 13 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.11077102 |
| 14 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.07791591 |
| 15 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 2.00331364 |
| 16 | ABC transporters_Homo sapiens_hsa02010 | 1.95087340 |
| 17 | Protein export_Homo sapiens_hsa03060 | 1.90591295 |
| 18 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.83548280 |
| 19 | Circadian rhythm_Homo sapiens_hsa04710 | 1.82603932 |
| 20 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.81101580 |
| 21 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.80406307 |
| 22 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.77665480 |
| 23 | GABAergic synapse_Homo sapiens_hsa04727 | 1.75947712 |
| 24 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.73783265 |
| 25 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.72610337 |
| 26 | Cocaine addiction_Homo sapiens_hsa05030 | 1.64168218 |
| 27 | Long-term depression_Homo sapiens_hsa04730 | 1.64072429 |
| 28 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.62738903 |
| 29 | Morphine addiction_Homo sapiens_hsa05032 | 1.58445015 |
| 30 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.56884463 |
| 31 | Taste transduction_Homo sapiens_hsa04742 | 1.56132534 |
| 32 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.54640713 |
| 33 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.53677550 |
| 34 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.51748381 |
| 35 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.51536249 |
| 36 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.49443788 |
| 37 | Axon guidance_Homo sapiens_hsa04360 | 1.47682353 |
| 38 | Long-term potentiation_Homo sapiens_hsa04720 | 1.43973275 |
| 39 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.43121749 |
| 40 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.42222534 |
| 41 | Ribosome_Homo sapiens_hsa03010 | 1.41388678 |
| 42 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.39439535 |
| 43 | Circadian entrainment_Homo sapiens_hsa04713 | 1.36830293 |
| 44 | Phototransduction_Homo sapiens_hsa04744 | 1.33190444 |
| 45 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.30318759 |
| 46 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.25220132 |
| 47 | Renin secretion_Homo sapiens_hsa04924 | 1.22835465 |
| 48 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.21050294 |
| 49 | Salivary secretion_Homo sapiens_hsa04970 | 1.20543856 |
| 50 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.20398386 |
| 51 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.15028456 |
| 52 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.13197862 |
| 53 | Peroxisome_Homo sapiens_hsa04146 | 1.10881140 |
| 54 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.10082602 |
| 55 | Asthma_Homo sapiens_hsa05310 | 1.09423055 |
| 56 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.06895101 |
| 57 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.06574596 |
| 58 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.05268944 |
| 59 | Allograft rejection_Homo sapiens_hsa05330 | 1.04708688 |
| 60 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.04243659 |
| 61 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.99259324 |
| 62 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.98309959 |
| 63 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.97980093 |
| 64 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.95452313 |
| 65 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.91901549 |
| 66 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.90730911 |
| 67 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.89993300 |
| 68 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.89310613 |
| 69 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.89148516 |
| 70 | RNA polymerase_Homo sapiens_hsa03020 | 0.87921650 |
| 71 | Platelet activation_Homo sapiens_hsa04611 | 0.87864214 |
| 72 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.87758415 |
| 73 | Basal transcription factors_Homo sapiens_hsa03022 | 0.87706107 |
| 74 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.83738412 |
| 75 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.83015568 |
| 76 | Gap junction_Homo sapiens_hsa04540 | 0.78403374 |
| 77 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.77484589 |
| 78 | Retinol metabolism_Homo sapiens_hsa00830 | 0.76498475 |
| 79 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.76367052 |
| 80 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.76237689 |
| 81 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.75683984 |
| 82 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.75548449 |
| 83 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.75383616 |
| 84 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.74980622 |
| 85 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.74359617 |
| 86 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.73762803 |
| 87 | RNA degradation_Homo sapiens_hsa03018 | 0.73722869 |
| 88 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.73307458 |
| 89 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.73041421 |
| 90 | Insulin secretion_Homo sapiens_hsa04911 | 0.71944937 |
| 91 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.71747363 |
| 92 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.71002505 |
| 93 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.70739719 |
| 94 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.70555640 |
| 95 | Proteasome_Homo sapiens_hsa03050 | 0.69755389 |
| 96 | Olfactory transduction_Homo sapiens_hsa04740 | 0.68583495 |
| 97 | Alcoholism_Homo sapiens_hsa05034 | 0.66625848 |
| 98 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.66600902 |
| 99 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.66015585 |
| 100 | Lysine degradation_Homo sapiens_hsa00310 | 0.65999068 |
| 101 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.64756858 |
| 102 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.64258667 |
| 103 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.62997265 |
| 104 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.61142111 |
| 105 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.60292382 |
| 106 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.59805575 |
| 107 | Histidine metabolism_Homo sapiens_hsa00340 | 0.59244398 |
| 108 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.58698566 |
| 109 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.57921724 |
| 110 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.57805995 |
| 111 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.56298825 |
| 112 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.53590031 |
| 113 | Measles_Homo sapiens_hsa05162 | 0.51996373 |
| 114 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.51843401 |
| 115 | Leishmaniasis_Homo sapiens_hsa05140 | 0.51118153 |
| 116 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.50724378 |
| 117 | Melanogenesis_Homo sapiens_hsa04916 | 0.50064108 |
| 118 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.48940421 |
| 119 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.48118456 |
| 120 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.45577284 |
| 121 | Metabolic pathways_Homo sapiens_hsa01100 | 0.44982859 |
| 122 | Prion diseases_Homo sapiens_hsa05020 | 0.44467206 |
| 123 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.43390475 |
| 124 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.43056315 |
| 125 | Phagosome_Homo sapiens_hsa04145 | 0.43032718 |
| 126 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.41380467 |
| 127 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.41340954 |
| 128 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.41315596 |
| 129 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.40351444 |
| 130 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.40242375 |
| 131 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.39266026 |
| 132 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.39104032 |
| 133 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.38895289 |
| 134 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.38688593 |
| 135 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.38308275 |
| 136 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.36075601 |
| 137 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.35107188 |
| 138 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.34999468 |
| 139 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.32227774 |
| 140 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.30566698 |
| 141 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.30035897 |
| 142 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.29007570 |
| 143 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.24371737 |
| 144 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.24150865 |
| 145 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.23086329 |
| 146 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.22453172 |
| 147 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.20263183 |
| 148 | Mineral absorption_Homo sapiens_hsa04978 | 0.20204693 |
| 149 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.20019803 |
| 150 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.19195618 |
| 151 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.15612745 |

